Ultragenyx Pharmaceutical Inc.

NASDAQ:RARE

Biotechnology

Healthcare
$17.22 +3.01%

+$0.81 today

Market cap
$1.76B
Beta
0.38
P/E (TTM)
-4.6
EPS (TTM)
-$6.06
52W Low $18.29High $42.37

Volume 3.12M

Average 1.81M

Price history

Ultragenyx Pharmaceutical Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-44.77%

Period high

$36.54

Period low

$12.88

Latest

$17.22

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
SC 13GNov 10, 2026Nov 10, 2026
10-QNov 4, 2026Nov 3, 2026
8-KNov 3, 2026Nov 3, 2026
SC 13G/AOct 30, 2026Oct 30, 2026
SC 13GOct 20, 2026Oct 20, 2026
4Oct 19, 2026Oct 19, 2026
8-KOct 19, 2026Oct 19, 2026
8-KOct 14, 2026Oct 14, 2026
8-KOct 7, 2026Oct 7, 2026
8-KSep 17, 2026Sep 17, 2026
4Sep 15, 2026Sep 15, 2026
4Sep 8, 2026Sep 8, 2026
8-KSep 2, 2026Sep 2, 2026
8-KAug 19, 2026Aug 19, 2026

Competitors

Who does Ultragenyx Pharmaceutical Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about RARE's filings, answered from its disclosures.

What is the latest RARE filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does RARE have?

Intrinsic Alpha currently shows 20 recent filings for RARE.